Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment
Authors
Keywords
-
Journal
DRUG RESISTANCE UPDATES
Volume 66, Issue -, Pages 100904
Publisher
Elsevier BV
Online
2022-11-29
DOI
10.1016/j.drup.2022.100904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine
- (2022) Valentin Van den bossche et al. DRUG RESISTANCE UPDATES
- First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA
- (2022) Thomas John et al. International Journal of Clinical Oncology
- Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer
- (2022) Poonam Banthia et al. 3 Biotech
- The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
- (2022) Cristina P.R. Xavier et al. DRUG RESISTANCE UPDATES
- Clinical implications of germline variations for treatment outcome and drug resistance for small molecule kinase inhibitors in patients with non-small cell lung cancer
- (2022) Niels Heersche et al. DRUG RESISTANCE UPDATES
- Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
- (2022) Sihong Chen et al. DRUG RESISTANCE UPDATES
- A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy
- (2022) Qian Chen et al. JOURNAL OF CONTROLLED RELEASE
- Genotoxicity and in vitro investigation of Gefitinib-loaded polycaprolactone fabricated nanoparticles for anticancer activity against NCI-H460 cell lines
- (2022) Sankha Bhattacharya Journal of Experimental Nanoscience
- Association of anticoagulant use with clinical outcomes from crizotinib in ALK ‐ and ROS1 ‐rearranged advanced non‐small cell lung cancers: A retrospective analysis of PROFILE 1001
- (2022) Terry L. Ng et al. Cancer Medicine
- Long non-coding RNA mediated drug resistance in breast cancer
- (2022) Deepshikha Singh et al. DRUG RESISTANCE UPDATES
- The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
- (2022) Philippe Icard et al. DRUG RESISTANCE UPDATES
- Genetic alterations shaping tumor response to anti-EGFR therapies
- (2022) Javier Vaquero et al. DRUG RESISTANCE UPDATES
- Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
- (2021) Jing-Quan Wang et al. DRUG RESISTANCE UPDATES
- Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
- (2021) Luciana Mosca et al. DRUG RESISTANCE UPDATES
- Targeted nanomedicine modalities for prostate cancer treatment
- (2021) Lital Cohen et al. DRUG RESISTANCE UPDATES
- Biological effects of formation of protein corona onto nanoparticles
- (2021) Rakesh Kumar Mishra et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Advances in Drug Resistance of Esophageal Cancer: From the Perspective of Tumor Microenvironment
- (2021) Siyuan Luan et al. Frontiers in Cell and Developmental Biology
- Novel nanomedicines to overcome cancer multidrug resistance
- (2021) Zhenwei Su et al. DRUG RESISTANCE UPDATES
- The role of endolysosomal trafficking in anticancer drug resistance
- (2021) Noor A. Hussein et al. DRUG RESISTANCE UPDATES
- Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis
- (2021) Lipeng Zhu et al. International Journal of Nanomedicine
- Smart nanocarriers as therapeutic platforms for bladder cancer
- (2021) Tongyu Tong et al. Nano Research
- Molecular pathogenesis of hereditary lung cancer: a literature review
- (2021) Souraya Rammal et al. PHARMACOGENOMICS
- Hypoxia as a driver of resistance to immunotherapy
- (2021) Joanna Kopecka et al. DRUG RESISTANCE UPDATES
- Tumour Microenvironment Stress Promotes the Development of Drug Resistance
- (2021) Nicole A. Seebacher et al. Antioxidants
- Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy
- (2020) Shi Gao et al. ACS Nano
- Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
- (2020) Margaret M. Billingsley et al. NANO LETTERS
- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives
- (2020) Eunus S. Ali et al. SEMINARS IN CANCER BIOLOGY
- Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
- (2020) Christopher Woodman et al. SEMINARS IN CANCER BIOLOGY
- Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
- (2020) Wenxiao Jiang et al. DRUG RESISTANCE UPDATES
- Nanomedicine to target multidrug resistant tumors
- (2020) Elise Lepeltier et al. DRUG RESISTANCE UPDATES
- Theranostic approaches in nuclear medicine: current status and future prospects
- (2020) Luca Filippi et al. Expert Review of Medical Devices
- Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment
- (2020) Lei Li et al. NANO LETTERS
- EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX ‐351) for the Treatment of Adults with Newly Diagnosed, Therapy‐Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia‐Related Changes
- (2020) Kyriaki Tzogani et al. ONCOLOGIST
- Lung Cancer: Advances in Diagnosis and Management
- (2020) Percy Lee et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Unintended ICD discharge in a patient undergoing bladder tumor resection utilizing monopolar cautery and full‐body return electrode
- (2020) Ryan J. Lefevre et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation
- (2020) Siddharth Adityan et al. JOURNAL OF CONTROLLED RELEASE
- Nanomodified strategies to overcome EGFR-tyrosine kinase inhibitors resistance in non-small cell lung cancer
- (2020) Zi-Xian Liao et al. JOURNAL OF CONTROLLED RELEASE
- Gold Nanoparticles in Glioma Theranostics
- (2020) Mohammad Norouzi PHARMACOLOGICAL RESEARCH
- Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles
- (2020) Mohammad Norouzi et al. Scientific Reports
- Current Strategies for Treating NSCLC: From Biological Mechanisms to Clinical Treatment
- (2020) Junnan Li et al. Cancers
- In vivo gene delivery mediated by non-viral vectors for cancer therapy
- (2020) Reza Mohammadinejad et al. JOURNAL OF CONTROLLED RELEASE
- Clinical applications of nanomedicines in lung cancer treatment
- (2020) Mohammad Norouzi et al. Acta Biomaterialia
- The role of alternative splicing in cancer: From oncogenesis to drug resistance
- (2020) Rocco Sciarrillo et al. DRUG RESISTANCE UPDATES
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Nanomedicines accessible in the market for clinical interventions
- (2020) Vedant Gadekar et al. JOURNAL OF CONTROLLED RELEASE
- The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
- (2020) Muyue Yang et al. Bioactive Materials
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumors
- (2019) Michael J. Benchimol et al. JOURNAL OF DRUG TARGETING
- Nanotechnology in the diagnosis and treatment of lung cancer
- (2019) Alexander M. Cryer et al. PHARMACOLOGY & THERAPEUTICS
- Polymalic acid chlorotoxin nanoconjugate for near-infrared fluorescence guided resection of glioblastoma multiforme
- (2019) Rameshwar Patil et al. BIOMATERIALS
- Nanotechnology based therapeutics for lung disease
- (2019) Mohammad Doroudian et al. THORAX
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
- (2019) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
- (2019) Shira Engelberg et al. Cell Death & Disease
- Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
- (2019) Lv Chen et al. ADVANCED MATERIALS
- Clinical applications of nanomedicine in cancer therapy
- (2019) Mohammad Norouzi et al. DRUG DISCOVERY TODAY
- HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy
- (2019) Xiaojuan Zhang et al. CHEMICAL ENGINEERING JOURNAL
- Nanotechnology in Radiation Oncology
- (2019) Bo Sun et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Nano-immunotherapy: Overcoming tumour immune evasion
- (2019) Maria L. Guevara et al. SEMINARS IN CANCER BIOLOGY
- Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
- (2018) J Remon et al. ANNALS OF ONCOLOGY
- How the Warburg effect supports aggressiveness and drug resistance of cancer cells?
- (2018) Philippe Icard et al. DRUG RESISTANCE UPDATES
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes
- (2018) Zheng Yang et al. International Journal of Biological Sciences
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer
- (2018) Chang Liu et al. MOLECULAR PHARMACEUTICS
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Three-dimensional electrochemical DNA biosensor based on 3D graphene-Ag nanoparticles for sensitive detection of CYFRA21-1 in non-small cell lung cancer
- (2018) Mei Chen et al. SENSORS AND ACTUATORS B-CHEMICAL
- Salinomycin-loaded Nanofibers for Glioblastoma Therapy
- (2018) Mohammad Norouzi et al. Scientific Reports
- The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics
- (2018) Mengliu Yang et al. Frontiers in Pharmacology
- Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond
- (2018) Javed Iqbal et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Remodeling Tumor-Associated Macrophages and Neovascularization Overcomes EGFRT790M -Associated Drug Resistance by PD-L1 Nanobody-Mediated Codelivery
- (2018) Weimin Yin et al. Small
- Pembrolizumab for the treatment of non-small cell lung cancer
- (2017) Mirte Muller et al. Expert Review of Anticancer Therapy
- Paclitaxel: What has been done and the challenges remain ahead
- (2017) Ezequiel Bernabeu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Polymeric micelles: Basic research to clinical practice
- (2017) Anand S. Deshmukh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Characterization of pegylated and non-pegylated liposomal formulation for the delivery of hypoxia activated vinblastine- N -oxide for the treatment of solid tumors
- (2017) Vidhi M. Shah et al. JOURNAL OF CONTROLLED RELEASE
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
- (2017) Peter M Bruno et al. NATURE MEDICINE
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MAPK pathway inhibition induces MET and GAB1 levels, priming BRAF mutant melanoma for rescue by hepatocyte growth factor
- (2017) Sean Caenepeel et al. Oncotarget
- Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging
- (2017) Yi-Hsuan Chi et al. Theranostics
- Designing nanomedicine for immuno-oncology
- (2017) Wen Jiang et al. Nature Biomedical Engineering
- High-Density Lipoproteins: Nature’s Multifunctional Nanoparticles
- (2016) Rui Kuai et al. ACS Nano
- Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy
- (2016) Kai Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Reactive oxygen species acts as executor in radiation enhancement and autophagy inducing by AgNPs
- (2016) Hao Wu et al. BIOMATERIALS
- Tumor-associated macrophages and anti-tumor therapies: complex links
- (2016) Cristina Belgiovine et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
- (2016) D. D. Von Hoff et al. CLINICAL CANCER RESEARCH
- Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer
- (2016) Yueling Yuan et al. DRUG DELIVERY
- Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer
- (2016) Shachar Raz et al. DRUG RESISTANCE UPDATES
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- Heparanase: From basic research to therapeutic applications in cancer and inflammation
- (2016) Israel Vlodavsky et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Electrochemical biosensors and nanobiosensors
- (2016) J. L. Hammond et al. Essays in Biochemistry
- Simultaneous detection of five biomarkers of lung cancer by electrochemical immunoassay
- (2016) Jiao Shan et al. MICROCHIMICA ACTA
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo–photodynamic combination therapy
- (2016) Wenxiu Hou et al. Nanoscale
- Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
- (2016) Aaron N Hata et al. NATURE MEDICINE
- Erratum: The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
- (2016) Danny N. Khalil et al. Nature Reviews Clinical Oncology
- Reporter nanoparticle that monitors its anticancer efficacy in real time
- (2016) Ashish Kulkarni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
- (2016) Jun Wang et al. OncoTargets and Therapy
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- The role of recent nanotechnology in enhancing the efficacy of radiation therapy
- (2015) Judith W.J. Bergs et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A high sensitive electrochemical aptasensor for the determination of VEGF 165 in serum of lung cancer patient
- (2015) Mahmoud Amouzadeh Tabrizi et al. BIOSENSORS & BIOELECTRONICS
- Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
- (2015) Khalid O Alfarouk et al. Cancer Cell International
- Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach
- (2015) Sophie Taylor et al. DRUG RESISTANCE UPDATES
- In vivo evaluation of PEGylated 64Cu-liposomes with theranostic and radiotherapeutic potential using micro PET/CT
- (2015) Anncatrine Luisa Petersen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic challenges in non-small-cell lung cancer: an integrated medicine approach
- (2015) Ravi Salgia Future Oncology
- Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics
- (2015) Ganeshlenin Kandasamy et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study
- (2015) Erik Thunnissen et al. Journal of Thoracic Oncology
- Gold nanoparticles as contrast agents in x-ray imaging and computed tomography
- (2015) Lisa E Cole et al. Nanomedicine
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Applications of polymer micelles for imaging and drug delivery
- (2015) Sara Movassaghian et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- The Role of Multidrug Resistance Efflux Pumps in Cancer: Revisiting a JNCI Publication Exploring Expression of the MDR1 (P-glycoprotein) Gene
- (2015) Michael M. Gottesman et al. JNCI-Journal of the National Cancer Institute
- Enhancing Lung Cancer Diagnosis: Electrochemical Simultaneous Bianalyte Immunosensing Using Carbon Nanotubes–Chitosan Nanocomposite
- (2014) Meenakshi Choudhary et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Small cell lung cancer: Where do we go from here?
- (2014) Lauren Averett Byers et al. CANCER
- Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
- (2014) Guanying Chen et al. CHEMICAL REVIEWS
- Molecular Pathways: Linking Tumor Microenvironment to Epithelial-Mesenchymal Transition in Metastasis
- (2014) H.-Y. Jung et al. CLINICAL CANCER RESEARCH
- Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects
- (2014) Sutapa Barua et al. Nano Today
- Gd-containing conjugated polymer nanoparticles: bimodal nanoparticles for fluorescence and MRI imaging
- (2014) Zeina Hashim et al. Nanoscale
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanopreparations to overcome multidrug resistance in cancer
- (2013) Niravkumar R. Patel et al. ADVANCED DRUG DELIVERY REVIEWS
- Electrochemical immunosensor for simultaneous detection of multiplex cancer biomarkers based on graphene nanocomposites
- (2013) Xia Chen et al. BIOSENSORS & BIOELECTRONICS
- Lower gefitinib dose led to earlier resistance acquisition before emergence of T790M mutation in epidermal growth factor receptor-mutated lung cancer model
- (2013) Hiromi Hayakawa et al. CANCER SCIENCE
- Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial
- (2013) Sung Yong Lee et al. Clinical Lung Cancer
- Correction to Mass Production and Size Control of Lipid–Polymer Hybrid Nanoparticles through Controlled Microvortices
- (2013) YongTae Kim et al. NANO LETTERS
- Cancer Nanomedicine: From Drug Delivery to Imaging
- (2013) E. K.-H. Chow et al. Science Translational Medicine
- Biomarkers and biosensors for the early diagnosis of lung cancer
- (2013) Zeynep Altintas et al. SENSORS AND ACTUATORS B-CHEMICAL
- Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation
- (2012) Stefanie Klein et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma
- (2012) Han Wang et al. BIOMATERIALS
- The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy
- (2012) Tennyson L. Doane et al. CHEMICAL SOCIETY REVIEWS
- Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
- (2012) Nitzan Gonen et al. DRUG RESISTANCE UPDATES
- Weeklynab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
- (2012) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- A combination approach for rapid and high yielding purification of bacterial minicells
- (2012) Mehul Jivrajani et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Rapid Discovery of Potent siRNA-Containing Lipid Nanoparticles Enabled by Controlled Microfluidic Formulation
- (2012) Delai Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles
- (2011) Han Wang et al. BIOMATERIALS
- Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapy
- (2011) Sanda C. Boca et al. CANCER LETTERS
- Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: A systematic review
- (2011) Mark Murphy et al. DRUG RESISTANCE UPDATES
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents
- (2010) Anke de Vries et al. BIOMATERIALS
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- Cost-Effectiveness of Genexol-PM for Treating Metastatic Breast Cancer
- (2010) Jinhyun Kim et al. Journal of Breast Cancer
- In vitrocytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells
- (2010) Guoqin Niu et al. JOURNAL OF DRUG TARGETING
- Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T1 contrast
- (2010) Jeyarama S. Ananta et al. Nature Nanotechnology
- Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
- (2010) D Ercan et al. ONCOGENE
- Liposomes Coloaded with Iopamidol/Lipiodol as a RES-Targeted Contrast Agent for Computed Tomography Imaging
- (2010) Soonjae Kweon et al. PHARMACEUTICAL RESEARCH
- Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
- (2009) Sophie Laurent et al. CHEMICAL REVIEWS
- Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy
- (2009) Robert W. Ross et al. CLINICAL IMAGING
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
- (2008) Qian Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Microfluidic Platform for Controlled Synthesis of Polymeric Nanoparticles
- (2008) Rohit Karnik et al. NANO LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search